Operating Lease, Weighted Average Discount Rate, Percent of MoonLake Immunotherapeutics from 31 Dec 2022 to 31 Dec 2025

Taxonomy & unit
us-gaap: pure
Description
Weighted average discount rate for operating lease calculated at point in time.
Summary
MoonLake Immunotherapeutics quarterly Operating Lease, Weighted Average Discount Rate, Percent in pure history and change rate from 31 Dec 2022 to 31 Dec 2025.
  • MoonLake Immunotherapeutics Operating Lease, Weighted Average Discount Rate, Percent for the quarter ending 31 Dec 2025 was 0.046, a 2.1% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Weighted Average Discount Rate, Percent, Quarterly (pure)
Operating Lease, Weighted Average Discount Rate, Percent, YoY Quarterly Change (%)

MoonLake Immunotherapeutics Quarterly Operating Lease, Weighted Average Discount Rate, Percent (pure)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 0.046 -0.001 -2.1% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 0.047 0 0% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 0.047 -0.001 -2.1% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 0.047 -0.001 -2.1% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 0.047 -0.002 -4.1% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 0.047 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 0.048 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 0.048 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 0.049 +0.041 +512% 31 Dec 2023 10-K 26 Feb 2025 2024 FY
Q4 2022 0.008 31 Dec 2022 10-K 29 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.